Blocking of NF-κB activation enhances the tumor necrosis factor α-induced apoptosis of a human gastric cancer cell line

Cancer Letters

Volumn 193, Issue 2, 2003, Pages 177-182

  Ueda, Miho ^a   Kokura, Satoshi ^a   Imamoto, Eiko ^a   Naito, Yuji ^a   Handa, Osamu ^a   Takagi, Tomohisa ^a   Yoshida, Norimasa ^a   Yoshikawa, Toshikazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Apoptosis; Nuclear factor B (NF B); Proteasome inhibitor; Tumor necrosis factor (TNF )

Indexed keywords

ALDEHYDE; DNA FRAGMENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N CARBOBENZOXYISOLEUCYLGLUTAMYL O TERT BUTYLALANYLLEUCINAL; PROTEASOME INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYSTEINE PROTEINASE; MULTIENZYME COMPLEX; PROTEASOME; RECOMBINANT PROTEIN; UBIQUITIN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL VIABILITY; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STAINING; STOMACH CANCER; CELL CULTURE; CELL SURVIVAL; DOSE RESPONSE; DRUG ANTAGONISM; METABOLISM; STOMACH TUMOR; TIME;

APOPTOSIS; CELL SURVIVAL; CYSTEINE ENDOPEPTIDASES; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MICROSCOPY, FLUORESCENCE; MULTIENZYME COMPLEXES; NF-KAPPA B; PROTEASOME ENDOPEPTIDASE COMPLEX; RECOMBINANT PROTEINS; STOMACH NEOPLASMS; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITIN;

EID: 0037466423     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00002-8     Document Type: Article

References (21)

1. Van Antwerp D.J., Martin S.J., Kafri T., Green D.R., Verma I.M. Suppression of TNF-α-induced apoptosis by NF-κB. Science. 274:1996;787-789.
2. Beg A.A., Baltimore D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science. 274:1996;782-784.
3. Wang C.-Y., Mayo M.W., Baldwin A.S. Jr. TNF and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science. 274:1996;784-787.
4. Naito Y., Handa O., Takagi T., Ishikawa T., Imamoto E., Nakagawa S., Yamaguchi T., Yoshida N., Matsui H., Yoshikawa T. Ubiquitin-proteasome inhibitor enhances tumor necrosis factor-α-induced apoptosis in rat gastric epithelial cells. Aliment Pharmacol. Ther. 16:2002;59-66.
5. Hojo H. Establishment of culture cell lines of human stomach cancer; origin and their morphological characteristics. Niigata Med. J. 91:1977;737-752.
6. Schreiber E., Matthias P., Muller M.M., Schaffner W. Rapid detection octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucl. Acids Res. 11:1989;6419.
7. Nakajima H., Park H.L., Henkart P.A. Synergistic roles of granzymes A and B in mediating target cell death by rat basophilic leukemia/mast cell tumors also expressing cytolysin/perforin. J. Exp. Med. 181:1995;1037-1046.
8. Adams J., Stein R. Novel inhibitors of the proteasome and their therapeutic use in inflammation. Annu. Rep. Med. Chem. 31:1996;279-288.
9. Drexler H.C.A. Activation of the cell death program by inhibition of proteasome function. Proc. Natl. Acad. Sci. USA. 94:1997;855-860.
10. Tanimoto Y., Onishi Y., Hashimoto S., Kizaki H. Peptidyl aldehyde inhibitors of proteasome induce apoptosis rapidly in mouse lymphoma RVC cells. J. Biochem. 121:1997;542-549.
11. Sasaki N., Morisaki T., Hashizume K., Yao T., Tsuneyoshi M., Noshiro H., Nakamura K., Yamanaka T., Uchiyama A., Tanaka M., Katano M. Nuclear factor-κB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin. Cancer Res. 7:2001;4136-4142.
12. Wang W., Abbruzzese J.L., Evans D.B., Larry L., Cleary K.R., Chiao P.J. The nuclear factor-κB RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin. Cancer Res. 5:1999;119-127.
13. Sovak M.A., Bellas R.E., Kim D.W., Zanieski G.J., Rogers A.E., Traish A.M., Sonenshein G.E. Aberrant nuclear factor-κB//Rel expression and the pathogenesis of breast cancer. J. Clin. Invest. 100:1997;952-2960.
14. Ichikawa H., Flores S., Kvietys P.R., Wolf R.E., Yoshikawa T., Granger D.N., Aw T.Y. Molecular mechanisms of anoxia/reoxygenation-induced neutrophil adherence to cultured endothelial cells. Circ. Res. 81:1997;922-931.
15. Kokura S., Wolf R.E., Yoshikawa T., Granger D.N., Aw T.Y. Molecular mechanisms of neutrophil-endothelial cell adhesion induced by redox imbalance. Circ. Res. 84:1999;516-524.
16. Imamoto E., Kokura S., Ueda M., Uchiyama K., Kuchide M., Naito Y., Yoshida N., Yoshikawa T. A relationship between hypoxia/reoxygenation and E-cadherin expression. Free Radic. Biol. Med. 33:2002;S165.
17. Basu S., Rosenzweig K.R., Youmell M., Price B.D. The DNA-dependent protein kinase participates in the activation of NF kappa B following DNA damage. Biochem. Biophys. Res. Commun. 247:1998;79-83.
18. Neish A.S., Williams A.J., Palmer H.J., Whitley M.Z., Collins T. Functional analysis of the human vascular cell adhesion molecule-1 promoter. J. Exp. Med. 176:1992;1583-1593.
19. Huang S., Pettaway C.A., Uehara H., Bucana C.D., Fidler I.J. Blockade of NF-κB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene. 20:2001;4188-4197.
20. Inoue H., Tanabe T. Transcriptional role of the nuclear factor kappaB site in the induction by lipopolysaccharide and suppression by dexamethasone of cyclooxygenase-2 in U937 cells. Biochem. Biophys. Res. Commun. 244:1998;143-148.
21. Newton R., Kuitert L.M., Bergmann M., Adcock I.M., Barnes P.J. Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1 beta. Biochem. Biophys. Res. Commun. 237:1997;28-32.